Apoptosis and expression of Bcl-2, Bax, p53, caspase-3, and Fas, Fas ligand in placentas complicated by preeclampsia

Clinical and Experimental Obstetrics and Gynecology

Volumn 38, Issue 1, 2011, Pages 38-42

  Mendilcioglu, I ^a   Karaveli, S ^a   Erdogan, G ^a   Simsek, M ^a   Taskin, O ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Placenta; Preeclampsia

Indexed keywords

CASPASE 3; FAS ANTIGEN; FAS LIGAND; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; DNA FRAGMENTATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PROTEIN EXPRESSION; TROPHOBLAST;

ADULT; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 79954990970     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kerr J.F., Wyllie A.H., Currie A.R.: "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics". Br. J. Cancer, 1972, 26, 239.
2. Edinger A.L., Thompson C.B.: "Death by design: apoptosis, necrosis and autophagy". Curr. Opin. Cell. Biol., 2004, 16, 663.
3. Heazell A.E., Crocker I.P.: "Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies". Placenta, 2008, 29, 772.
4. Sibai B.M.: "Diagnosis and management of gestational hypertension and preeclampsia". Obstet. Gynecol., 2003, 102, 181.
5. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., Lessey B.A.: "Placental apoptosis in preeclampsia". Obstet. Gynecol., 2000, 90, 271.
6. Leung D.N., Smith S.C., To K.F., Sahota D.S., Baker P.N.: "Increased placental apoptosis in pregnancies complicated by preeclampsia". Am. J. Obstet. Gynecol., 2001, 184, 1249.
7. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., Maruo T.: "Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation". Am. J. Obstet. Gynecol., 2002, 186, 158.
8. Fadeel B., Orrenius S.: "Apoptosis: a basic biological phenomenon with wideranging implications in human disease". J. Intern. Med., 2005, 258, 479.
9. Huppertz B., Frank H.G., Kingdom J.C., Reister F., Kaufmann P.: "Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta". Histochem. Cell Biol., 1998, 110, 495.
10. Ratts V.S., Tao X.J., Webster C.B., Swanson P.E., Smith S.D., Brownbill P. et al: "Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium". Placenta, 2000, 21, 361.
11. Yamada Z., Kitagawa M., Takemura T., Hirokawa K.: "Effect of maternal age on indices of apoptotic and proliferative cells in trophoblasts of full-term placenta". Mol Hum. Reprod., 2001, 7, 1179.
12. Haupt S., Berger M., Goldberg Z., Haupt Y.: "Apoptosis - the p53 network". J. Cell Sci., 2003, 116, 4077.
13. Marzusch K., Ruck P., Horny H.-P., Died J., Kaiserling E.: "Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study". Placenta, 1995, 16, 101.
14. Alexander G.R., Himes J.H., Kaufman R.B., Mor J.M., Kogan M.D.: "A U.S. national reference for fetal growth". Obstet. Gynecol., 1996, 87, 163.
15. Alexander G.R., Kogan M., Martin J., Papiernik E.: "What are the fetal growth patterns of singletons, twins, and triplets in the United States?". Clin. Obstet. Gynecol., 1998, 41, 114.
16. Levy R., Smith S.D., Chandler K., Sadovsky Y., Nelson D.M.: "Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor". Am. J. Physiol. Cell. Physiol., 2000, 278, 982.
17. Heazell A.E., Lacey H.A., Jones C.J., Huppertz B., Baker P.N., Crocker I.P.: "Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast". Placenta, 2008, 29, 175.
18. Goswami D., Tannetta D.S., Magee L.A., Fuchisawa A., Redman C.W., Sargent I.L. et al.: "Excess syncytiotrophoblast microparticle shedding is a feature of early onset pre-eclampsia, but not normotensive intrauterine growth restriction". Placenta, 2006, 27, 56.
19. Knight M., Redman C.W., Linton E.A., Sargent I.L.: "Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies". BJOG, 1998, 105, 632.
20. Smarason A.K., Sargent I.L., Starkey P.M., Redman C.W.G.: "The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro". Br. J. Obstet. Gynaecol., 1993, 100, 943.
21. Cockell A.P., Learmont J.G., Smarason A.K., Redman C.W.G., Sargent I.L., Poston L.: "Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function". Br. J. Obstet. Gynaecol., 1997, 104, 235.
22. Abumaree M.H., Stone P.R., Chamley L.W.: "An in vitro model of human placental trophoblast deportation/shedding". Mol Hum. Reprod., 2006, 12, 687.
23. Levy R., Smith S.D., Yusuf K., Huettner P.C., Kraus F.T., Sadovsky Y. et al.: "Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression". Am. J. Obstet. Gynecol., 2002, 186, 1056.
24. Jeschke U., Schiessl B., Mylonas I., Kunze S., Kuhn C., Schulze S. et al.: "Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies". Int. J. Gynecol. Pathol., 2006, 25, 354.
25. Endo H., Okamoto A., Yamada K., Nikaido T., Tanaka T.: "Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms". Int. J. Mol. Med., 2005, 16, 79.
26. Heazell A.E., Buttle H., Baker P.N., Crocker I.P.: "Altered Expression of regulators of caspase activity within trophoblast of normal pregnancies and pregnancies complicated by preeclampsia". Reprod. Sci., 2008, 15, 1034.
27. Neale D.M., Mor G.: "The role of Fas mediated apoptosis in preeclampsia". J. Perinat. Med., 2005, 33, 471.
28. von Dadelszen P., Watson R.W., Noorwali F., Marshall J.C., Parodo J., Farine D. et al.: "Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction". Am. J. Obstet. Gynecol., 1999, 181, 408.
29. von Dadelszen P., Magee L.A., Roberts J.M.: "Subclassification of preeclampsia". Hypertens Pregnancy, 2003, 22, 143.
30. Huppertz B.: "Placental origins of preeclampsia: challenging the current hypothesis". Hypertension, 2008, 51, 970.
31. Smith S.C., Baker P.N., Symonds E.M.: "Placental apoptosis in normal human pregnancy". Am. J. Obstet. Gynecol., 1997, 177, 57.
32. Sprott H., Salemi S., Gay R.E., Bradley L.A., Alarcón G.S., Oh S.J. et al.: "Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres". Ann. Rheum. Dis., 2004, 63, 245.